Gannet BioChem
Kris Johnson currently serves as the Vice President of Quality at Gannet BioChem, overseeing GxP compliance and collaborating with senior leaders to establish a strategic vision that enhances employee focus. Prior experience includes a significant tenure at Nektar Therapeutics, where Kris held multiple leadership roles, culminating as Vice President of Quality, responsible for GMP, GCP, and GLP compliance. Prior positions encompass ownership of Johnson Investments, General Manager/QA Director at U.S. Diagnostics, Director of Quality Assurance at Nektar Therapeutics, Quality/Regulatory Manager at Qualitest Pharmaceuticals, Compliance Specialist at S.S.S. Company, and Quality Control Auditor at Schering-Plough. Kris Johnson holds a Bachelor of Science in Microbiology and Chemistry from Auburn University.
This person is not in any teams
This person is not in any offices
Gannet BioChem
With over 30 years of expertise, Gannet BioChem is a leading specialty CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic products. Operating from a state-of-the-art 124,000 sq. ft. FDA-inspected facility in Huntsville, Alabama, Gannet BioChem delivers end-to-end GMP production, supporting clinical and commercial therapeutics. With a highly experienced team, flexible production capabilities, and a commitment to quality, Gannet BioChem provides reliable, innovative solutions to meet the evolving needs of the global biopharmaceutical industry.